ZA919662B - Pharmaceutical preparations containing functionalized vinyl azoles,use of these vinyl azoles for the production of pharmaceutical agents,vinyl azoles themselves as well as process for their production - Google Patents
Pharmaceutical preparations containing functionalized vinyl azoles,use of these vinyl azoles for the production of pharmaceutical agents,vinyl azoles themselves as well as process for their productionInfo
- Publication number
- ZA919662B ZA919662B ZA919662A ZA919662A ZA919662B ZA 919662 B ZA919662 B ZA 919662B ZA 919662 A ZA919662 A ZA 919662A ZA 919662 A ZA919662 A ZA 919662A ZA 919662 B ZA919662 B ZA 919662B
- Authority
- ZA
- South Africa
- Prior art keywords
- production
- vinyl azoles
- azoles
- vinyl
- themselves
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 2
- -1 vinyl azoles Chemical class 0.000 title 2
- 229920002554 vinyl polymer Polymers 0.000 title 2
- MZNSQRLUUXWLSB-UHFFFAOYSA-N 2-ethenyl-1h-pyrrole Chemical class C=CC1=CC=CN1 MZNSQRLUUXWLSB-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008177 pharmaceutical agent Substances 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4039559A DE4039559A1 (de) | 1990-12-07 | 1990-12-07 | Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA919662B true ZA919662B (en) | 1992-09-30 |
Family
ID=6420083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA919662A ZA919662B (en) | 1990-12-07 | 1991-12-06 | Pharmaceutical preparations containing functionalized vinyl azoles,use of these vinyl azoles for the production of pharmaceutical agents,vinyl azoles themselves as well as process for their production |
Country Status (17)
Country | Link |
---|---|
US (1) | US5344834A (he) |
EP (1) | EP0550697A1 (he) |
JP (1) | JPH06503818A (he) |
KR (1) | KR930703263A (he) |
CN (1) | CN1064863A (he) |
AU (1) | AU660296B2 (he) |
CA (1) | CA2097824C (he) |
CS (1) | CS369691A3 (he) |
DE (1) | DE4039559A1 (he) |
FI (1) | FI932572A (he) |
HU (1) | HUT64036A (he) |
IE (1) | IE914259A1 (he) |
IL (1) | IL100274A (he) |
NO (1) | NO304428B1 (he) |
PT (1) | PT99714B (he) |
WO (1) | WO1992010482A1 (he) |
ZA (1) | ZA919662B (he) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5418250A (en) * | 1989-06-14 | 1995-05-23 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
GB2273704B (en) * | 1992-12-16 | 1997-01-22 | Orion Yhtymae Oy | Triazolyl diaryl selective aromatase inhibiting compounds |
US5395847A (en) * | 1993-12-02 | 1995-03-07 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids |
EP0943333A1 (de) * | 1998-03-18 | 1999-09-22 | S.W. Patentverwertungs GmbH | Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen |
US20020086856A1 (en) | 1998-03-18 | 2002-07-04 | Alfred Schmidt | Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
CN100358866C (zh) * | 2004-04-08 | 2008-01-02 | 上海交通大学 | 含对强碱不稳定取代基的n-乙烯基取代吡咯的制备方法 |
JP6470984B2 (ja) * | 2015-01-27 | 2019-02-13 | 学校法人東日本学園 | アロマターゼ阻害剤及びこれを含む医薬 |
CN105732977B (zh) * | 2016-01-30 | 2018-03-02 | 宝鸡文理学院 | 一种可溶性聚苯并二噻唑‑酰胺荧光聚合物及其制备方法和应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1580535A (en) * | 1976-08-27 | 1980-12-03 | Ici Ltd | Substituted ketones and their use as herbicides |
EP0003884A3 (en) * | 1978-02-23 | 1979-09-19 | Imperial Chemical Industries Plc | Alpha-beta unsaturated ketone derivatives useful as herbicides |
DE2826760A1 (de) * | 1978-06-19 | 1980-01-03 | Hoechst Ag | Derivate des 1,2,4-triazols |
JPS62149666A (ja) * | 1985-12-25 | 1987-07-03 | Shionogi & Co Ltd | N−ビニルアゾ−ル類 |
US4749713A (en) * | 1986-03-07 | 1988-06-07 | Ciba-Geigy Corporation | Alpha-heterocycle substituted tolunitriles |
GB8716650D0 (en) * | 1987-07-15 | 1987-08-19 | Ici Plc | Use of olefinic compounds |
-
1990
- 1990-12-07 DE DE4039559A patent/DE4039559A1/de not_active Withdrawn
-
1991
- 1991-12-05 CS CS913696A patent/CS369691A3/cs unknown
- 1991-12-06 ZA ZA919662A patent/ZA919662B/xx unknown
- 1991-12-06 PT PT99714A patent/PT99714B/pt not_active IP Right Cessation
- 1991-12-06 CN CN91112779A patent/CN1064863A/zh active Pending
- 1991-12-08 IL IL10027491A patent/IL100274A/he not_active IP Right Cessation
- 1991-12-09 EP EP19920900266 patent/EP0550697A1/de not_active Withdrawn
- 1991-12-09 IE IE425991A patent/IE914259A1/en unknown
- 1991-12-09 KR KR1019930701698A patent/KR930703263A/ko not_active Application Discontinuation
- 1991-12-09 CA CA002097824A patent/CA2097824C/en not_active Expired - Fee Related
- 1991-12-09 AU AU90454/91A patent/AU660296B2/en not_active Ceased
- 1991-12-09 JP JP4500378A patent/JPH06503818A/ja active Pending
- 1991-12-09 WO PCT/EP1991/002359 patent/WO1992010482A1/de not_active Application Discontinuation
- 1991-12-09 HU HU931657A patent/HUT64036A/hu unknown
- 1991-12-09 US US07/802,639 patent/US5344834A/en not_active Expired - Fee Related
-
1993
- 1993-06-04 FI FI932572A patent/FI932572A/fi unknown
- 1993-06-04 NO NO932044A patent/NO304428B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
DE4039559A1 (de) | 1992-06-11 |
WO1992010482A1 (de) | 1992-06-25 |
PT99714B (pt) | 1999-05-31 |
IL100274A0 (en) | 1992-09-06 |
AU660296B2 (en) | 1995-06-22 |
PT99714A (pt) | 1992-10-30 |
CN1064863A (zh) | 1992-09-30 |
IE914259A1 (en) | 1992-06-17 |
HUT64036A (en) | 1993-11-29 |
JPH06503818A (ja) | 1994-04-28 |
NO932044L (no) | 1993-06-04 |
CA2097824A1 (en) | 1992-06-08 |
EP0550697A1 (de) | 1993-07-14 |
FI932572A0 (fi) | 1993-06-04 |
NO304428B1 (no) | 1998-12-14 |
NO932044D0 (no) | 1993-06-04 |
HU9301657D0 (en) | 1993-09-28 |
KR930703263A (ko) | 1993-11-29 |
US5344834A (en) | 1994-09-06 |
IL100274A (he) | 1996-08-04 |
FI932572A (fi) | 1993-06-04 |
AU9045491A (en) | 1992-07-08 |
CA2097824C (en) | 2003-04-08 |
CS369691A3 (en) | 1992-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA965752B (en) | Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents. | |
HU911815D0 (en) | Process for the production of medical preparations containing pravastatine for the prevention of, relapse after vasodilator operation | |
HU912452D0 (en) | Process for the production of medical preparations containing organic compounds | |
AU7820191A (en) | New imidazole derivatives, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them | |
AU1274888A (en) | Process for preparing 1,1,1-trifluoro-2,2-dichloroethane by hydrofluorination in the presence of catalysts | |
HU9201937D0 (en) | Aryl ethers, process for their production, and for the production of medical preparations containing them as active agents | |
HU910929D0 (en) | Process for the production of 2,8-dioxa-bicyclo/3,2,1/octane derivatives and medical preparations containing them | |
EP0445589A3 (en) | Process for the preparation of 1,4-alkylenediamines | |
HU911750D0 (en) | Process for the production of medical preparations containing substituted betha-hydroxy-ethylamines | |
ZA919662B (en) | Pharmaceutical preparations containing functionalized vinyl azoles,use of these vinyl azoles for the production of pharmaceutical agents,vinyl azoles themselves as well as process for their production | |
HU905358D0 (en) | Substituted bicycloheptane-dion-derivatives, process for the production of the compounds, and herbicide preparations containing the derivatives | |
HU913267D0 (en) | Process for the production of 1-(3,4-dihydro-2-oxo-1h-kinoline-6-yl)-2-(4-)2-phenyl-ethyl-(piperidine-1-yl)-ethanole and ethanone, and of medical preparations containing them as active agents | |
HU9200354D0 (en) | Process for the production of 2-ethyl-4-/2'/-1h-1,2,3,4-tetrazole-5-yl/-biphenyl-4-yl/-metoxi/-kinoline-hydrocloride | |
ZA905932B (en) | 14,17alpha-etheno-and-ethanoestratrienes,processes for the preparation of these compounds,as well as their use for the production of medicinal agents | |
ZA916433B (en) | Novel pyrrolobenzimidazoles,imidazobenzoxazinones and imidazoquinolones,process for their preparation and their use and preparations containing the compounds | |
EP0292808A3 (en) | Substituted vinyl cephalosporins, process for their preparation and their use as medicines | |
HU9201358D0 (en) | 2-amino-pirimidine-4-carboxamide derivatives, process for their production and for the production of medical preparations containing them as active agents | |
EP0297296A3 (en) | Process for the preparation of 2,2'-oxybisûn,n-dimethyl-ethylamine¨ | |
AU624746B2 (en) | Process for the preparation of 5-amino-3-chlorosulfonyl-1,2,4-triazole | |
ZA949347B (en) | 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceutical agents containing these compounds and process for their production. | |
ZA914376B (en) | Benzimidazole derivatives,their preparation process,the intermediates obtained,their use as medicaments and the pharmaceutical compositions containing them | |
GB2272218B (en) | Process for the preparation of 2,4,6-triiodo-isophthalic acid bis-(1,3-dihydroxypropylamide) derivatives | |
EP0475272A3 (en) | Process for the preparation of 2,3,5-trimethyl-p-benzoquinone | |
AU2886595A (en) | Technetium-sulphonamide complexes, their use, pharmaceutical agents containing the latter, as well as process for the production of the complexes and agents | |
HU913228D0 (en) | Process for the production of 5-aroil-2,3-dihydro-1h-pyrrholyzine-1,1-dicarboxylates |